- E. Coli Fears Spur Recall of 167,000 Pounds of Ground Beef
- Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
- Nearly 160 Million Americans Harmed by Another’s Drinking, Drug Use
- 1 in 4 Americans Now Struggling to Cover Medical Costs
- Getting Fitter Can Really Help Keep Dementia at Bay
- Skin Patch Could Monitor Your Blood Pressure
- There May Be a Better Way to Treat Hematoma Brain Bleeds
- Chronic Joint Pain Plus Depression Can Take Toll on the Brain
- Living in Space Won’t Permanently Harm Astronauts’ Thinking Skills
- Kids’ Injuries in Sports and at Home: When Is It Right to Seek Medical Attention?
More DNA Errors Seen in Brain Cells of Alzheimer’s Patients
Genetic mutations build up faster in the brain cells of Alzheimer’s disease patients than in other people, new research reveals.
The discovery could point the way to new Alzheimer’s treatments.
DNA errors called somatic mutations can occur in brain cells as people age. The authors of this study compared somatic mutations in hippocampal and prefrontal cortex neurons of people with advanced Alzheimer’s and people with no neurological conditions.
The Alzheimer’s disease (AD) patients had a larger number of mutations — likely due to increased DNA oxidation, according to findings published April 20 in the journal Nature.
“As we age, neurons are known to accumulate somatic mutations. In AD neurons, however, we see more mutations and DNA alterations,” said lead study author Dr. Michael Miller, a neuropathologist at Harvard-affiliated Brigham and Women’s Hospital in Boston.
“Our results suggest that AD neurons experience genomic damage that causes immense stress on cells and creates dysfunction among them,” he added. “These findings may explain why many brain cells die during Alzheimer’s disease.”
The study provides more insight into the molecular and cellular events involved in the development of Alzheimer’s.
“Our findings suggest that the sheer number of oxidative lesions and somatic mutations we observed in AD neurons may contribute to its pathology,” Miller said in a hospital news release.
In the future, the researchers are eager to learn more about how the mutations work and to discover novel treatments that target them.
This study included only patients with advanced Alzheimer’s, so researchers want to examine the brain cells of people with intermediate-stage Alzheimer’s in the future.
More information
For more on Alzheimer’s disease, go to the U.S. National Institute on Aging.
SOURCE: Brigham and Women’s Hospital, news release, April 20, 2022
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.